Le Lézard
Classified in: Health
Subjects: RCL, PSF

Public advisory - Unauthorized amoxicillin capsules seized from Green Fresh Supermarket in Ottawa, ON, may pose serious health risks


OTTAWA, ON, May 27, 2023 /CNW/ - 

Summary
Images

Amoxicillin Capsules (CNW Group/Health Canada)

Affected products

Amoxicillin Capsules

Issue

Health Canada is warning consumers about unauthorized amoxicillin capsules that it seized from Green Fresh Supermarket in Ottawa (175 McArthur Ave.), Ontario, because the product may pose serious health risks. It is labelled to contain amoxicillin, a prescription antibiotic drug used to treat certain bacterial infections.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should be used only under the supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Amoxicillin may cause severe allergic reactions with symptoms including swollen lips, face and throat, difficulty breathing, severe skin rashes and itchiness, nausea, vomiting, diarrhea, and signs of kidney and liver failure. It should not be used by patients with known allergies to drugs containing amoxicillin. Patients with allergies to other antibiotic types may also experience allergic reactions to amoxicillin. Misuse or overuse could lead to growth of bacteria that will not be killed by amoxicillin and means that the antibiotic may not work in the future when required (this is known as antibiotic resistance).

What you should do

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: